A study led by researchers from The University of Texas MD Anderson Cancer Center showed a significant overall survival benefit with ribociclib plus endocrine therapy for postmenopausal patients with hormone receptor-positive ...
Sep 19, 2021
0
17
(HealthDay)—When Nancy Cappello was diagnosed with advanced breast cancer in 2003, she was stunned.
Sep 13, 2021
0
17
Combining a histone deacetylase inhibitor drug with immunotherapy agents is safe, and may benefit some patients with advanced cancers that have not responded to traditional therapy, according to results of a phase 1 clinical ...
Aug 16, 2021
0
18
Medical researchers at Flinders University have established a new link between high body mass index (BMI) and breast cancer survival rates—with clinical data revealing worse outcomes for early breast cancer (EBC) patients ...
Apr 30, 2021
0
11
A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows.
Mar 11, 2021
0
9
The first study to compare molecular landscapes of early-onset and late-onset appendiceal cancer has revealed distinct non-silent mutations in the tumors of younger patients, setting the stage for the development of potential ...
Dec 9, 2020
0
0
A blood test that can identify a variety of mutations in advanced breast cancer can reliably match women to effective targeted treatments, early results of a major clinical trial reveal.
Sep 11, 2020
0
4
EU regulators have approved Novartis's new Piqray drug to treat advanced breast cancer, the Swiss pharma giant said Wednesday.
Jul 29, 2020
0
5
Cancer's untold toll may be a financial one, especially among young women fighting advanced breast cancer.
Jun 10, 2020
0
4
Up to now, women who present with a new diagnosis of breast cancer that is already in an advanced stage (stage IV) face an unanswered question about whether surgery and radiation to the tumor in the breast (local therapy) ...
May 29, 2020
0
3
